Opus IVS™ Sets New Standards with Eight Patent Innovations
Opus IVS™ Expands Its Patent Portfolio
Driving innovation in the automotive servicing industry
Opus IVS™, a leading name in automotive diagnostics, programming, and remote support, has taken a significant step forward by securing eight new U.S. patents recently. This accomplishment underscores the company's dedication to enhancing vehicle service intelligence and delivering cutting-edge technological solutions for automotive repair professionals around the globe.
Leading the Automotive Diagnostic Frontier
This year’s notable patent achievements include Application No. 17/509,316, which focuses on a "Vehicle Diagnostic System and Method for Providing Repair Recommendations." This innovative technology empowers service professionals with intelligent, data-driven insights that refine diagnostic accuracy and drive customer satisfaction. Also included is the approved Application No. 19/051,744, titled "Adaptive Vehicle Service Information Querying System and Method," that represents a new age in dynamic service data retrieval, ensuring technicians have immediate access to essential repair processes tailored to specific vehicle needs.
Commitment to Continuous Innovation
With a portfolio that features over 100 patents and numerous applications worldwide, Opus IVS is at the forefront of developing remote diagnostics and Advanced Driver Assistance Systems (ADAS) services. The company’s expanding range of intellectual properties encompasses critical areas such as vehicle network communication, remote programming capabilities, ADAS calibration management, and automated service intelligence.
Brian Herron, CEO of Opus IVS, articulates, "Our unwavering aim has always been customer-driven innovation. Each newly secured patent is a stride toward equipping repair experts with more empowered, connected, and efficient service options. At Opus IVS, innovation isn’t merely a department—it’s embedded in our culture."
Enhancing Success in Automotive Repairs
Through its groundbreaking platforms like DriveSafe™ and CoPilot™, as well as ADASMap™ and IVS Calibrate™, Opus IVS is revolutionizing how repair shops access real-time vehicle insights, remote OEM assistance, and automated work tools. This integration streamlines diagnostic processes, facilitating quicker and more reliable repairs for customers.
"For us, innovation is not a theory; it’s practical," Herron commented, further emphasizing, "These advancements are designed to help our clients address complex challenges daily, whether dealing with intricate electrical diagnostics, managing ADAS calibrations, or executing remote reflash services. Opus IVS technologies transform potential challenges into rewarding opportunities."
Showcasing Innovations at SEMA
Opus IVS will be prominently featuring its latest offerings, including DrivePro2™ and DriveSafe2™, at the upcoming Specialty Equipment Market Association (SEMA) Show. Taking place in November in Las Vegas, attendees are invited to visit Booth #32087 located in the South Upper Hall for exciting product demonstrations.
About Opus IVS
As a division of the Opus Group, Opus IVS brings together various industry leaders, including DrewTech, Autologic, Farsight, BlueLink, Autotechcelerators, and AutoEnginuity. Together, they provide innovative solutions to over 65,000 repair shops and dealerships worldwide. With a strong emphasis on OEM-endorsed diagnostic technology, Opus IVS is continuously advancing in remote flash programming, pre- and post-repair diagnostics, ADAS calibrations, and vehicle network solutions. The company also excels in providing remote technical support, linking repair clients with an extensive team of brand-specific Dealer Master Technicians for tailored assistance.
Part of the Opus Group, which employs over 2,900 individuals with 35 offices around the globe, Opus IVS conducts tests on 35 million vehicles yearly to ensure compliance with on-board diagnostics standards.
Contact Information
For further information, please visit Opusivs.com. You can also reach us at (877) 945-6442.
For Press Inquiries
Jim Fish can be contacted at (248) 480-6996 for any press-related queries.
Frequently Asked Questions
What is Opus IVS™ known for?
Opus IVS™ specializes in automotive diagnostics, programming, and remote support, providing innovative solutions to repair shops globally.
How many patents has Opus IVS™ secured?
Opus IVS™ has secured eight new patents and holds over 100 patents and applications pending worldwide, reinforcing their industry leadership.
What products will Opus IVS™ showcase at SEMA?
At SEMA, Opus IVS™ will showcase products such as DrivePro2™ and DriveSafe2™, along with various other cutting-edge innovations.
Who is the CEO of Opus IVS™?
The CEO of Opus IVS™ is Brian Herron, who emphasizes the company’s commitment to innovation and customer service.
How can customers contact Opus IVS™?
Customers can contact Opus IVS™ through their website, Opusivs.com, or by calling (877) 945-6442.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.